Ims Capital Management Amgen Inc Transaction History

Ims Capital Management

$217 Million
Q2 2024

A detailed history of Ims Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Ims Capital Management holds 5,335 shares of AMGN stock, worth $1.54 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

5,335

Previous 5,934 10.09%

Holding current value

$1.54 Million

Previous $1.69 Million 1.24%

% of portfolio

0.77%

Previous 0.79%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 21, 2024	SELL	$262.75 - $319.31 $157,387 - $191,266	-599 Reduced 10.09%	5,335 $1.67 Million
Q1 2024 Jun 12, 2024	BUY	$268.87 - $324.56 $154,869 - $186,946	576 Added 10.75%	5,934 $1.69 Million
Q4 2023 Apr 01, 2024	BUY	$255.7 - $288.46 $383,805 - $432,978	1,501 Added 38.92%	5,358 $1.54 Million
Q2 2023 Sep 13, 2023	BUY	$214.27 - $253.37 $328,904 - $388,922	1,535 Added 66.11%	3,857 $856,000
Q3 2022 Nov 17, 2022	SELL	$224.46 - $253.15 $6,958 - $7,847	-31 Reduced 1.32%	2,322 $523,000
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $13,150 - $14,634	57 Added 2.48%	2,353 $572,000
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $10,963 - $12,128	-50 Reduced 2.13%	2,296 $555,000
Q4 2021 Jan 05, 2022	BUY	$198.88 - $227.6 $63,243 - $72,376	318 Added 15.68%	2,346 $528,000
Q3 2021 Oct 07, 2021	BUY	$212.27 - $248.7 $58,374 - $68,392	275 Added 15.69%	2,028 $431,000
Q2 2021 Jul 07, 2021	SELL	$233.58 - $259.14 $290,807 - $322,629	-1,245 Reduced 41.53%	1,753 $427,000
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $249,648 - $290,925	1,125 Added 60.06%	2,998 $746,000
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $18,175 - $21,644	-84 Reduced 4.29%	1,873 $431,000
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $156,269 - $191,764	-790 Reduced 28.76%	1,957 $462,000
Q1 2020 Apr 03, 2020	SELL	$182.24 - $241.7 $261,514 - $346,839	-1,435 Reduced 34.31%	2,747 $557,000
Q4 2019 Jan 15, 2020	BUY	$189.21 - $243.2 $4,730 - $6,080	25 Added 0.6%	4,182 $1.01 Million
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $430,922 - $516,334	2,475 Added 147.15%	4,157 $804,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $3,891 - $4,386	-21 Reduced 1.23%	1,682 $0
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $29,889 - $33,571	-180 Reduced 9.56%	1,703 $314,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $35,277 - $39,415	209 Added 12.49%	1,883 $327,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $280,043 - $319,734	1,674	1,674 $312,000

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Ims Capital Management with notifications on news.

Account

Ims Capital Management Amgen Inc Transaction History